FRANKLIN RESOURCES INC - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2016. The put-call ratio across all filers is 269.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q4 2016$28,793,000
-43.9%
2,173,022
+0.3%
0.02%
-44.4%
Q3 2016$51,354,000
-28.0%
2,166,825
-12.5%
0.03%
-28.9%
Q2 2016$71,352,000
-3.8%
2,475,482
+6.9%
0.04%
-2.6%
Q1 2016$74,173,000
-29.9%
2,316,406
-6.4%
0.04%
-27.8%
Q4 2015$105,778,000
-10.0%
2,473,698
-25.9%
0.05%
-6.9%
Q3 2015$117,531,000
-23.4%
3,337,933
-0.1%
0.06%
-17.1%
Q2 2015$153,430,000
-2.3%
3,341,232
-0.2%
0.07%
-1.4%
Q1 2015$156,980,000
+97.2%
3,349,284
+33.3%
0.07%
+97.2%
Q4 2014$79,615,000
+318.3%
2,513,082
+213.0%
0.04%
+300.0%
Q3 2014$19,034,000
-16.1%
802,808
+6.1%
0.01%
-10.0%
Q2 2014$22,685,000
+111.0%
756,406
+85.9%
0.01%
+100.0%
Q1 2014$10,750,000
-45.7%
406,898
-48.3%
0.01%
-50.0%
Q4 2013$19,801,000
+40.7%
787,613
+14.8%
0.01%
+42.9%
Q3 2013$14,069,000
+5.3%
685,947
+2.4%
0.01%
-12.5%
Q2 2013$13,360,000669,7310.01%
Other shareholders
IMPAX LABORATORIES INC shareholders Q4 2016
NameSharesValueWeighting ↓
Orbimed Advisors 5,415,600$162,414,0001.91%
Broadfin Capital, LLC 1,217,858$36,524,0001.80%
NEW AMSTERDAM PARTNERS LLC/NY 695,100$20,846,0001.36%
Healthcare Value Capital, LLC 50,000$1,500,0001.26%
Iguana Healthcare Management, LLC 75,000$2,249,0001.05%
Matarin Capital Management, LLC 78,292$2,347,977,0001.04%
Independence Capital Asset Partners, LLC 253,089$7,590,0001.04%
Tekla Capital Management LLC 344,683$10,337,0000.95%
Penn Capital Management Company, LLC 794,641$23,831,0000.92%
Leonard Capital Management, Inc. 87,661$2,629,0000.89%
View complete list of IMPAX LABORATORIES INC shareholders